242 results on '"Richer, Lawrence"'
Search Results
2. Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada
3. Stratification of risk for emergent intracranial abnormalities in children with headaches: a Pediatric Emergency Care Applied Research Network (PECARN) study protocol.
4. Analgesic Use Among Adults with a Trauma-Related Emergency Department Visit: A Retrospective Cohort Study from Alberta, Canada
5. Disease-modifying therapy use and health resource utilisation associated with multiple sclerosis over time: A retrospective cohort study from Alberta, Canada
6. Interobserver Agreement in the Assessment of Clinical Findings in Children with Headaches
7. Early analgesic administration and headache presence 7 days post-concussion in children
8. Inequities in the Use of Disease-Modifying Therapy Among Adults Living With Multiple Sclerosis in Urban and Rural Areas in Alberta, Canada.
9. Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study
10. Quality of life, respiratory symptoms, and health care utilization 1 year following outpatient management of COVID-19: a prospective cohort study
11. Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
12. Poststroke Care Pathways and Spasticity Treatment: A Retrospective Study in Alberta
13. Interobserver Agreement in the Assessment of Clinical Findings in Children with Headaches
14. Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition
15. Geographical variation in medication and health resource use in multiple sclerosis
16. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance
17. Effect of lower body negative pressure on cardiac and cerebral function in postural orthostatic tachycardia syndrome: A pilot MRI assessment
18. Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
19. The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
20. Medication use of Canadians with chronic obstructive pulmonary disease: a cohort study
21. Benzodiazepine Use in Medical Cannabis Authorization Adult Patients from 2013-2021: Alberta, Canada
22. The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader–Willi syndrome
23. Trajectory of health care resources among adults stopping or reducing treatment frequency of botulinum toxin for chronic migraine treatment in Alberta, Canada
24. Autonomic Cardioregulatory Function Does Not Correlate With Symptom Improvement After Concussion in Children and Adolescents
25. Patient-reported outcomes of neurologic and neuropsychiatric symptoms in mild COVID-19: a prospective cohort study
26. Autonomic Cardioregulatory Function Does Not Correlate With Symptom Improvement After Concussion in Children and Adolescents.
27. Evaluation of Autonomic Nervous System Dysfunction in Childhood Obesity and Prader–Willi Syndrome
28. Hydroxychloroquine for treatment of non‐hospitalized adults with COVID ‐19: A meta‐analysis of individual participant data of randomized trials
29. A randomized trial of ketorolac and metoclopramide for migraine in the emergency department
30. Additional file 5 of Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
31. Additional file 2 of Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
32. Additional file 2 of Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study
33. Additional file 1 of Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
34. Additional file 5 of Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study
35. Additional file 3 of Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
36. Additional file 1 of Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study
37. Additional file 4 of Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study
38. Additional file 4 of Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
39. Tic Versus TAC: Differentiating the Neuralgias (Trigeminal Neuralgia) from the Cephalalgias (SUNCT and SUNA)
40. Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study
41. Correction to: A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences (Trials, (2021), 22, 1, (206), 10.1186/s13063-021-05164-1)
42. Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED
43. S962 Comparing Cortiment® and Prednisone in Ulcerative Colitis: A Population-based Study of Outcomes
44. Randomized Controlled Trial of Treatment Expectation and Intravenous Fluid in Pediatric Migraine
45. A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences
46. Additional file 2 of Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
47. Characteristics of Adults with Migraine in Alberta, Canada: A Population-Based Study
48. Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial
49. Tuberous Sclerosis With Open Lipped Schizencephaly
50. Novel Infantile-Onset Leukoencephalopathy With High Lactate Level and Slow Improvement
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.